Danske Bank A S acquired a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, HoldingsChannel reports. The fund acquired 2,760 shares of the conglomerate’s stock, valued at approximately $1,987,000.
Several other institutional investors also recently bought and sold shares of the company. Main Street Group LTD acquired a new stake in shares of Danaher in the 1st quarter worth $25,000. N.E.W. Advisory Services LLC acquired a new position in shares of Danaher during the second quarter worth about $25,000. JPL Wealth Management LLC acquired a new position in shares of Danaher during the third quarter worth about $25,000. WFA of San Diego LLC purchased a new position in Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter worth about $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Trading Up 1.6%
Shares of Danaher stock opened at $219.42 on Friday. The company has a 50-day moving average of $195.80 and a two-hundred day moving average of $192.61. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market cap of $154.25 billion, a PE ratio of 38.97, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on DHR shares. TD Cowen lowered their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. HSBC cut their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Piper Sandler started coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Evercore reaffirmed an “outperform” rating and set a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Finally, Citigroup assumed coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.
Get Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
